You just read:

Milestone Pharmaceuticals Provides Positive Regulatory Updates for Etripamil Pivotal Program in PSVT and Reports Second Quarter 2019 Financial Results

News provided by

Milestone Pharmaceuticals, Inc.

Aug 13, 2019, 07:00 ET